Evaluation of Hepatoprotective Effect of a Polyherbal Formulation against Carbon Tetrachloride-Induced Hepatotoxicity in Rats

M. N. Huda, A. Mosaddik
{"title":"Evaluation of Hepatoprotective Effect of a Polyherbal Formulation against Carbon Tetrachloride-Induced Hepatotoxicity in Rats","authors":"M. N. Huda, A. Mosaddik","doi":"10.4172/2327-5162.1000262","DOIUrl":null,"url":null,"abstract":"Background: Millions of people suffer and die from liver diseases every year in worldwide. Viral hepatitis is a very common problem in Bangladesh however management is problematic and expensive in conventional medicine. So Ayurvedic medicine is way to solve the problem. Methods: This study was carried out to investigate the hepatoprotective effect of Rohitakarista, a polyherbal formulation against carbon tetrachloride induced hepatotoxicity in rats. Male albino rats (Wistar strain) were divided into 4 groups namely groups I, II, III and IV. Group I served as normal control and received neither formulation nor carbon tetrachloride. Group II received CCl4 in dose of 1ml per kg body weight intraperitoneally. Group III and IV received CCl4 1ml per kg body weight intraperitoneally plus Silymarin, in dose 50 mg/kg orally and Rohitakarista 1ml per kg body weight of rat respectively. After 14 days, blood was obtained for the determination of serum bilirubin, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase. The histological study was also carried out. Result: The result showed that polyherbal formulation exhibited a significant hepatoprotective effect when compared with standard Silymarin. Conclusion: Therefore this study suggests that polyherbal formulation Rohitakarista may have hepatoprotective activity.","PeriodicalId":90094,"journal":{"name":"Alternative & integrative medicine","volume":"7 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2327-5162.1000262","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative & integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2327-5162.1000262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Background: Millions of people suffer and die from liver diseases every year in worldwide. Viral hepatitis is a very common problem in Bangladesh however management is problematic and expensive in conventional medicine. So Ayurvedic medicine is way to solve the problem. Methods: This study was carried out to investigate the hepatoprotective effect of Rohitakarista, a polyherbal formulation against carbon tetrachloride induced hepatotoxicity in rats. Male albino rats (Wistar strain) were divided into 4 groups namely groups I, II, III and IV. Group I served as normal control and received neither formulation nor carbon tetrachloride. Group II received CCl4 in dose of 1ml per kg body weight intraperitoneally. Group III and IV received CCl4 1ml per kg body weight intraperitoneally plus Silymarin, in dose 50 mg/kg orally and Rohitakarista 1ml per kg body weight of rat respectively. After 14 days, blood was obtained for the determination of serum bilirubin, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase. The histological study was also carried out. Result: The result showed that polyherbal formulation exhibited a significant hepatoprotective effect when compared with standard Silymarin. Conclusion: Therefore this study suggests that polyherbal formulation Rohitakarista may have hepatoprotective activity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复方对四氯化碳所致大鼠肝毒性的保肝作用评价
背景:全世界每年有数百万人患有和死于肝脏疾病。病毒性肝炎在孟加拉国是一个非常普遍的问题,然而在传统医学中,管理是有问题的和昂贵的。所以阿育吠陀医学是解决这个问题的方法。方法:研究复方罗什丹对四氯化碳所致大鼠肝毒性的保护作用。雄性白化大鼠(Wistar品系)分为ⅰ、ⅱ、ⅲ、ⅳ组,ⅰ组为正常对照,不给方剂,不给四氯化碳。II组小鼠腹腔注射CCl4,剂量为每kg体重1ml。III组和IV组分别给予CCl4每公斤体重1ml腹腔注射加水飞蓟素,剂量为50 mg/kg口服,罗氏1ml每公斤体重口服。14 d后采血测定血清胆红素、谷丙转氨酶、天冬氨酸转氨酶和碱性磷酸酶。同时进行组织学研究。结果:与标准水飞蓟素相比,该复方具有明显的保肝作用。结论:本研究提示罗氏复方可能具有保护肝脏的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Unani Medicine in the Management of Tinnitus (Taneen) Stimulation of Phagocytosis in Alveolar Macrophages and Resistance against Infection in Mice by the Aqueous Extract of Rhizomes of Aframomum danielli, Schum (zingiberaceae) Efficacy of Fibromyalgia Treatment Using Bach Flower Therapy: Preliminary Results Challenges of Inappropriate Antibiotic Prescription in Dentistry and Threat of Antimicrobial Resistance in Developing Countries - Medicinal Plants to the Rescue Treatment of Dementia Symptoms: Scoping Review of Complementary and Alternative Medicine Approaches
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1